Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.71 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12946208 | 0.95 | MEN1 (0.69) | MEN1KMT2ATP53SIRT2HDAC1 | |
| SCHEMBL338138 | 0.94 | MEN1 (0.67) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL14363394 | 0.91 | MEN1 (0.64) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL12946172 | 0.89 | MEN1 (0.66) | MEN1KMT2ATP53HDAC2HDAC1 | |
| SCHEMBL6140750 | 0.88 | SIRT2 (0.59) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL15888707 | 0.87 | TP53 (0.58) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL15770775 | 0.86 | MEN1 (0.53) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL338745 | 0.85 | SIRT2 (0.56) | MEN1KMT2ATP53SIRT2HDAC2 | |
| SCHEMBL22129133 | 0.84 | CYP11B1 (0.60) | MEN1KMT2ATP53RAB9ANPC1 | |
| SCHEMBL16442425 | 0.84 | MAPT (0.62) | MEN1KMT2ATP53HDAC2HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11637256-B2 | Quantum dots with charge-transporting ligands | NANOSYS, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-11637256-B2 | Quantum dots with charge-transporting ligands | NANOSYS, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| CN-107820497-B | Imidazopyrazine derivatives for electronic devices | 陶氏环球技术有限责任公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-107602553-B | Organic small molecule electron transport material and preparation method and application thereof | 华南理工大学 | 2020-11-24 | — | — | CN | disclosed |
| US-10786683-B2 | Light-emitting devices for wound healing | NITTO DENKO CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| EP-3313843-B1 | IMIDAZOPYRAZINE DERIVED COMPOUNDS FOR ELECTRONIC DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-03-11 | — | — | EP | disclosed |
| WO-2020040982-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | WO | disclosed |
| WO-2020040982-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | WO | disclosed |
| US-20200067006-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | US | disclosed |
| US-20200067006-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | US | disclosed |
| CN-101812021-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO | 2010-08-25 | — | — | CN | disclosed |
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO., LTD, (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-2174933-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| EP-2174932-A2 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | Idemitsu Kosan Co., Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| CN-101503393-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2009-08-12 | — | — | CN | disclosed |
| US-20090184633-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090184633-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20060147747-A1 | 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage | IDEMITSU KOSAN CO., LTD. (JP) | 2006-07-06 | — | — | US | disclosed |
| CN-1784388-A | Nitrogen-containing heterocyclic derivative and organic electroluminescent element using same | IDEMITSU KOSAN CO (JP) | 2006-06-07 | — | — | CN | disclosed |
| EP-1602648-A1 | NITROGEN-CONTAINING HETEROCYCLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090184633-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative | H1-0, NQO2, GDI1 | MEN1 997/4885KMT2A 320/4885TP53 4781/4885 |
| US-20100193773-A1 | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same | NSD1, EED, ERG | MEN1 2259/4885KMT2A 526/4885TP53 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.